Available shipping options and any delivery estimates are shown during checkout
May 2024 data from KFF showed that 6% of adults currently take any GLP-1 drug, with 12% saying they have taken the medications at any point in time
With GLP-1 receptor agonists in the mix, glucagon secretion takes a back seat, leading to a decrease in glucose production in the liver
This stimulates lymphatic circulation, temporarily improves skin tone, and enhances ingredient absorption
In Phase 2 trials involving 338 participants across all doses, 88.8% of patients at the 12mg dose successfully completed the 48-week study despite experiencing side effects
If youre experiencing side effects that become difficult to manage, you shouldnt suffer through them